| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.4 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |